John A. Copland

48.1k total citations
157 papers, 7.2k citations indexed

About

John A. Copland is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, John A. Copland has authored 157 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Molecular Biology, 44 papers in Oncology and 31 papers in Cancer Research. Recurrent topics in John A. Copland's work include Thyroid Cancer Diagnosis and Treatment (22 papers), Cancer-related Molecular Pathways (17 papers) and Cancer, Hypoxia, and Metabolism (15 papers). John A. Copland is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (22 papers), Cancer-related Molecular Pathways (17 papers) and Cancer, Hypoxia, and Metabolism (15 papers). John A. Copland collaborates with scholars based in United States, Japan and Australia. John A. Copland's co-authors include Robert C. Smallridge, Laura A. Marlow, Mohammad Eghtedari, Alexander A. Oraevsky, Han W. Tun, Christina A. Von Roemeling, Massoud Motamedi, Simon Cooper, Nicholas A. Kotov and Melvyn S. Soloff and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

John A. Copland

152 papers receiving 7.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
John A. Copland 3.9k 1.7k 1.6k 1.2k 998 157 7.2k
Barry Trink 4.5k 1.2× 2.3k 1.4× 1.2k 0.7× 885 0.7× 761 0.8× 83 7.6k
Kristin Waite 3.9k 1.0× 1.4k 0.8× 1.7k 1.1× 473 0.4× 1.7k 1.7× 103 10.0k
Zhengping Zhuang 4.9k 1.3× 2.8k 1.7× 4.0k 2.6× 1.4k 1.1× 1.5k 1.5× 321 12.3k
Samuel R. Denmeade 4.4k 1.1× 2.6k 1.6× 2.2k 1.4× 1.1k 0.9× 4.3k 4.3× 223 9.8k
Toshiyuki Takeuchi 3.9k 1.0× 1.1k 0.7× 1.2k 0.8× 668 0.6× 1.2k 1.3× 178 8.3k
Jaetae Lee 2.3k 0.6× 791 0.5× 1.0k 0.7× 732 0.6× 589 0.6× 234 5.5k
Hing Y. Leung 5.3k 1.4× 1.6k 1.0× 1.8k 1.1× 279 0.2× 2.1k 2.2× 204 7.8k
Haiyen E. Zhau 3.9k 1.0× 2.8k 1.7× 1.8k 1.1× 259 0.2× 2.7k 2.7× 131 8.0k
Jeanette M. Wood 3.7k 1.0× 2.0k 1.2× 846 0.5× 374 0.3× 812 0.8× 103 7.5k
Craig Horbinski 4.5k 1.2× 1.7k 1.0× 2.5k 1.6× 225 0.2× 1.7k 1.7× 213 10.6k

Countries citing papers authored by John A. Copland

Since Specialization
Citations

This map shows the geographic impact of John A. Copland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Copland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Copland more than expected).

Fields of papers citing papers by John A. Copland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Copland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Copland. The network helps show where John A. Copland may publish in the future.

Co-authorship network of co-authors of John A. Copland

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Copland. A scholar is included among the top collaborators of John A. Copland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Copland. John A. Copland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rivera, Michael, Asha Nair, Yi Liu, et al.. (2024). BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression. Frontiers in Endocrinology. 15. 1440722–1440722.
2.
Hockla, Alexandra, et al.. (2024). Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension. Biomolecules. 14(9). 1187–1187. 2 indexed citations
3.
Wong, Tin Lok, Jia-Jian Loh, Shi‐Xun Lu, et al.. (2023). ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer. Nature Communications. 14(1). 2861–2861. 56 indexed citations
4.
Weinberger, Paul, et al.. (2022). YM155 Induces DNA Damage and Cell Death in Anaplastic Thyroid Cancer Cells by Inhibiting DNA Topoisomerase IIα at the ATP-Binding Site. Molecular Cancer Therapeutics. 21(6). 925–935. 6 indexed citations
5.
Tan, Winston, et al.. (2022). The Continuum of Metastatic Prostate Cancer: Interpreting PSMA PET Findings in Recurrent Prostate Cancer. Cancers. 14(6). 1361–1361. 7 indexed citations
6.
Landa, Iñigo, Nikita Pozdeyev, Christopher Korch, et al.. (2019). Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies. Clinical Cancer Research. 25(10). 3141–3151. 130 indexed citations
7.
Faigel, Douglas O., Eduard Sergienko, Andrey A. Bobkov, et al.. (2019). Molecular Inhibitor of QSOX1 Suppresses Tumor Growth In Vivo. Molecular Cancer Therapeutics. 19(1). 112–122. 19 indexed citations
8.
Drake, Richard R., Connor A. West, Thomas W. Powers, et al.. (2019). Defining the human kidney N‐glycome in normal and cancer tissues using MALDI imaging mass spectrometry. Journal of Mass Spectrometry. 55(4). e4490–e4490. 50 indexed citations
9.
Cichon, Magdalena A., Erin Miller, Christine Mehner, et al.. (2016). MYC Is a Crucial Mediator of TGFβ-Induced Invasion in Basal Breast Cancer. Cancer Research. 76(12). 3520–3530. 13 indexed citations
10.
Boufraqech, Myriem, Naris Nilubol, Lisa Zhang, et al.. (2014). miR30a Inhibits LOX Expression and Anaplastic Thyroid Cancer Progression. Cancer Research. 75(2). 367–377. 65 indexed citations
11.
Roemeling, Christina A. Von, Derek C. Radisky, Laura A. Marlow, et al.. (2014). Neuronal Pentraxin 2 Supports Clear Cell Renal Cell Carcinoma by Activating the AMPA-Selective Glutamate Receptor-4. Cancer Research. 74(17). 4796–4810. 156 indexed citations
12.
Smallridge, Robert C., John A. Copland, Marcia S. Brose, et al.. (2013). Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial. The Journal of Clinical Endocrinology & Metabolism. 98(6). 2392–2400. 93 indexed citations
13.
Roemeling, Christina A. Von, Laura A. Marlow, Simon Cooper, et al.. (2013). Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma. Clinical Cancer Research. 19(9). 2368–2380. 224 indexed citations
14.
Cooper, Simon, Christina A. Von Roemeling, Laura A. Marlow, et al.. (2012). Reexpression of Tumor Suppressor, sFRP1, Leads to Antitumor Synergy of Combined HDAC and Methyltransferase Inhibitors in Chemoresistant Cancers. Molecular Cancer Therapeutics. 11(10). 2105–2115. 52 indexed citations
15.
Hockla, Alexandra, Erin Miller, Moh’d A. Salameh, et al.. (2012). PRSS3/Mesotrypsin Is a Therapeutic Target for Metastatic Prostate Cancer. Molecular Cancer Research. 10(12). 1555–1566. 49 indexed citations
16.
Marlow, Laura A., Lisa A. Reynolds, Simon Cooper, et al.. (2009). Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer Growth. Cancer Research. 69(4). 1536–1544. 60 indexed citations
17.
Eghtedari, Mohammad, Anton V. Liopo, John A. Copland, Alexander A. Oraevsky, & Massoud Motamedi. (2008). Engineering of Hetero-Functional Gold Nanorods for the invivo Molecular Targeting of Breast Cancer Cells. Nano Letters. 9(1). 287–291. 192 indexed citations
18.
Kim, Jean Hee, Eric Jonasch, Angela Alexander, et al.. (2008). Cytoplasmic Sequestration of p27 via AKT Phosphorylation in Renal Cell Carcinoma. Clinical Cancer Research. 15(1). 81–90. 51 indexed citations
19.
Schweppe, Rebecca E., Joshua Klopper, Christopher Korch, et al.. (2008). Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification. The Journal of Clinical Endocrinology & Metabolism. 93(11). 4331–4341. 490 indexed citations
20.
Ma, Tianlin, John A. Copland, Allan R. Brasier, & E. Aubrey Thompson. (2000). A Novel Glucocorticoid Receptor Binding Element within the Murine c-myc Promoter. Molecular Endocrinology. 14(9). 1377–1386. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barry Trink Breakdown of academic impact, for papers by Kristin Waite Breakdown of academic impact, for papers by Zhengping Zhuang Breakdown of academic impact, for papers by Samuel R. Denmeade Breakdown of academic impact, for papers by Toshiyuki Takeuchi Breakdown of academic impact, for papers by Jaetae Lee Breakdown of academic impact, for papers by Hing Y. Leung Breakdown of academic impact, for papers by Haiyen E. Zhau Breakdown of academic impact, for papers by Jeanette M. Wood Breakdown of academic impact, for papers by Craig Horbinski
Rankless by CCL
2026